Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Brian J. Druker; Nicholas B. Lydon

doi:10.1172/JCI9083

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Brian J. Druker, Nicholas B. Lydon

Knight Cancer Institute

Research output: Contribution to journal › Review article › peer-review

824 Scopus citations

Original language	English (US)
Pages (from-to)	3-7
Number of pages	5
Journal	Journal of Clinical Investigation
Volume	105
Issue number	1
DOIs	https://doi.org/10.1172/JCI9083
State	Published - Jan 2000

ASJC Scopus subject areas

General Medicine

Access to Document

10.1172/JCI9083

Cite this

@article{6515ab3e0f7849b59462b87049a6fa99,

title = "Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia",

author = "Druker, {Brian J.} and Lydon, {Nicholas B.}",

year = "2000",

month = jan,

doi = "10.1172/JCI9083",

language = "English (US)",

volume = "105",

pages = "3--7",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "The American Society for Clinical Investigation",

number = "1",

}

TY - JOUR

T1 - Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

AU - Druker, Brian J.

AU - Lydon, Nicholas B.

PY - 2000/1

Y1 - 2000/1

UR - http://www.scopus.com/inward/record.url?scp=0033987746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033987746&partnerID=8YFLogxK

U2 - 10.1172/JCI9083

DO - 10.1172/JCI9083

M3 - Review article

C2 - 10619854

AN - SCOPUS:0033987746

SN - 0021-9738

VL - 105

SP - 3

EP - 7

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 1

ER -

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this